Michael Johnson - Quantitative 3D Tissue Imaging Accelerates Drug Discovery
Keynote: Quantitative 3D Tissue Imaging Accelerates Drug Discovery
Since the introduction of the microscope, researchers and clinicians have characterized tissues using ultra-thin slices that are placed on glass microscope slides and selectively stained. Michael will share how, at Visikol, they leverage quantitative histopathology and 3D tissue imaging so researchers can easily and quickly acquire 3D information from their tissues. How will this impact healthcare today and into the future?
- Michael Johnson, Visikol, CEO & Co-Founder
LDV Vision Summit 2018